Advantages of organ-sparing treatment approaches in metastatic kidney cancer.
J Cancer Res Clin Oncol
; 149(7): 3131-3137, 2023 Jul.
Article
in En
| MEDLINE
| ID: mdl-35870012
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Cancer Res Clin Oncol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: